CKc, in partnership with the V Foundation, awarded a $200,000 grant, at Purdue University Center for Cancer Research under the Tyler Trent Fund. The grant will help researchers at Purdue University conduct mouse studies with genetically-modified immune cells for glioblastoma, which is a promising but understudied approach for this diagnosis in the young adult population. By attacking glioblastoma from multiple angles, we will ultimately bring the promise of eradicating it closer to reality.
This Project By The Numbers
Years Active1 year